Dmitri Dvorzhinski

784 total citations
10 papers, 636 citations indexed

About

Dmitri Dvorzhinski is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dmitri Dvorzhinski has authored 10 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Dmitri Dvorzhinski's work include Cancer, Hypoxia, and Metabolism (4 papers), Autophagy in Disease and Therapy (3 papers) and Cell death mechanisms and regulation (2 papers). Dmitri Dvorzhinski is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Autophagy in Disease and Therapy (3 papers) and Cell death mechanisms and regulation (2 papers). Dmitri Dvorzhinski collaborates with scholars based in United States, United Kingdom and Saudi Arabia. Dmitri Dvorzhinski's co-authors include Robert S. DiPaola, Eileen White, Murugesan Gounder, Kevin Bray, Mark N. Stein, Susan Goodin, Hongxia Lin, Chandrika Jeyamohan, Simantini Eddy and Zoltán N. Oltvai and has published in prestigious journals such as Journal of Clinical Oncology, Cell Death and Disease and PROTEOMICS.

In The Last Decade

Dmitri Dvorzhinski

10 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dmitri Dvorzhinski United States 7 423 260 131 97 50 10 636
Yakir Guri Switzerland 7 567 1.3× 251 1.0× 102 0.8× 113 1.2× 49 1.0× 8 778
Weibo Zhou United States 7 456 1.1× 374 1.4× 82 0.6× 131 1.4× 33 0.7× 8 636
Rebecca C. Timson United States 6 548 1.3× 170 0.7× 112 0.9× 69 0.7× 79 1.6× 10 786
Sandra Mattu Italy 7 487 1.2× 359 1.4× 151 1.2× 97 1.0× 48 1.0× 8 800
Michihiko Waki Japan 17 428 1.0× 185 0.7× 53 0.4× 110 1.1× 50 1.0× 37 766
Cefan Zhou China 13 535 1.3× 334 1.3× 136 1.0× 129 1.3× 83 1.7× 38 758
Celia Garcı́a-Prieto United States 9 529 1.3× 322 1.2× 52 0.4× 174 1.8× 60 1.2× 12 863
Yung-Sheng Chang Taiwan 9 383 0.9× 223 0.9× 144 1.1× 111 1.1× 80 1.6× 10 673
Ge Lou China 15 585 1.4× 333 1.3× 66 0.5× 109 1.1× 50 1.0× 33 796
Gaëlle Bridon Canada 10 413 1.0× 214 0.8× 49 0.4× 81 0.8× 33 0.7× 12 555

Countries citing papers authored by Dmitri Dvorzhinski

Since Specialization
Citations

This map shows the geographic impact of Dmitri Dvorzhinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitri Dvorzhinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitri Dvorzhinski more than expected).

Fields of papers citing papers by Dmitri Dvorzhinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitri Dvorzhinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitri Dvorzhinski. The network helps show where Dmitri Dvorzhinski may publish in the future.

Co-authorship network of co-authors of Dmitri Dvorzhinski

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitri Dvorzhinski. A scholar is included among the top collaborators of Dmitri Dvorzhinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitri Dvorzhinski. Dmitri Dvorzhinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tedeschi, Philip M., Elke Markert, Murugesan Gounder, et al.. (2013). Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells. Cell Death and Disease. 4(10). e877–e877. 207 indexed citations
2.
Saleem, Ahamed, Dmitri Dvorzhinski, Urmila Santanam, et al.. (2012). Effect of dual inhibition of apoptosis and autophagy in prostate cancer. The Prostate. 72(12). 1374–1381. 53 indexed citations
3.
Stein, Mark N., Hongxia Lin, Chandrika Jeyamohan, et al.. (2010). Targeting tumor metabolism with 2‐deoxyglucose in patients with castrate‐resistant prostate cancer and advanced malignancies. The Prostate. 70(13). 1388–1394. 238 indexed citations
4.
DiPaola, Robert S., Dmitri Dvorzhinski, Michael May, et al.. (2008). Therapeutic starvation and autophagy in prostate cancer: A new paradigm for targeting metabolism in cancer therapy. The Prostate. 68(16). 1743–1752. 85 indexed citations
5.
DiPaola, Robert S., Dmitri Dvorzhinski, Michael May, et al.. (2007). Therapeutic starvation and autophagy in prostate cancer: A new paradigm. Journal of Clinical Oncology. 25(18_suppl). 10530–10530. 1 indexed citations
6.
DiPaola, Robert S., et al.. (2005). 2-deoxyglucose (2DG) bypasses Bcl-2 and Akt mediated resistance in prostate cells. Journal of Clinical Oncology. 23(16_suppl). 9535–9535. 1 indexed citations
7.
Dvorzhinski, Dmitri, Paul E. Thomas, Deirdre A. Nelson, et al.. (2004). A novel proteomic coculture model of prostate cancer cell growth. PROTEOMICS. 4(10). 3268–3275. 6 indexed citations
8.
White, Eileen, et al.. (2004). Epothilone induced cytotoxicity is dependent on p53 status in prostate cells. The Prostate. 61(3). 243–247. 18 indexed citations
9.
Doyle-Lindrud, Susan, Sue R. Beers, Susan Goodin, et al.. (2003). A phase I trial of weekly paclitaxel, 13- cis -retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies. Cancer Chemotherapy and Pharmacology. 52(2). 119–124. 21 indexed citations
10.
DiPaola, Robert S., et al.. (2003). Gemcitabine combined with sequential paclitaxel and carboplatin in patients with urothelial cancers and other advanced malignancies.. PubMed. 9(2). PI5–11. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026